This inventor holds 1 USPTO granted patent. Top assignee: Cibus US LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Robert W. Williams
Introduction
Robert W. Williams is an accomplished inventor based in Minneapolis, MN. He has made significant contributions to the field of biotechnology, particularly through his innovative patent work. His expertise and creativity have led to advancements that are shaping the future of genetic engineering.
Latest Patents
Robert W. Williams holds a patent for "Transcription activator-like effectors fused to inteins." This patent encompasses a variety of nucleotide sequences that encode a first intein fused to a portion of a transcription activator-like effector (TALE), a second nucleotide sequence with a similar fusion, and a third nucleotide sequence encoding a second intein fused to a rare-cutting nuclease. This invention has the potential to enhance gene editing techniques and improve the precision of genetic modifications.
Career Highlights
Throughout his career, Robert has demonstrated a strong commitment to innovation in biotechnology. He is currently employed at Cibus US LLC, where he continues to develop cutting-edge solutions in the field. His work has not only contributed to the scientific community but has also paved the way for practical applications in agriculture and medicine.
Collaborations
Robert has collaborated with various professionals in his field, including his coworker, Sara Wixon. Together, they have worked on projects that leverage their combined expertise to push the boundaries of genetic research.
Conclusion
Robert W. Williams is a notable inventor whose work in biotechnology is making a significant impact. His patent on transcription activator-like effectors fused to inteins exemplifies his innovative spirit and dedication to advancing genetic engineering. His contributions will undoubtedly continue to influence the field for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile